Genome-Wide Association Analysis in Asthma Subjects Identifies as a Novel Bronchodilator Response Gene

English version České info

Bronchodilator response (BDR) is an important asthma phenotype that measures reversibility of airway obstruction by comparing lung function (i.e. FEV₁) before and after the administration of a short-acting β₂-agonist, the most common rescue medications used for the treatment of asthma. BDR also serves as a test of β₂-agonist efficacy. BDR is a complex trait that is partly under genetic control. A genome-wide association study (GWAS) of BDR, quantified as percent change in baseline FEV₁ after administration of a β₂-agonist, was performed with 1,644 non-Hispanic white asthmatic subjects from six drug clinical trials: CAMP, LOCCS, LODO, a medication trial conducted by Sepracor, CARE, and ACRN. Data for 469,884 single-nucleotide polymorphisms (SNPs) were used to measure the association of SNPs with BDR using a linear regression model, while adjusting for age, sex, and height. Replication of primary P-values was attempted in 501 white subjects from SARP and 550 white subjects from DAG. Experimental evidence supporting the top gene was obtained via siRNA knockdown and Western blotting analyses. The lowest overall combined P-value was 9.7E-07 for SNP rs295137, near the SPATS2L gene. Among subjects in the primary analysis, those with rs295137 TT genotype had a median BDR of 16.0 (IQR = [6.2, 32.4]), while those with CC or TC genotypes had a median BDR of 10.9 (IQR = [5.0, 22.2]). SPATS2L mRNA knockdown resulted in increased β₂-adrenergic receptor levels. Our results suggest that SPATS2L may be an important regulator of β₂-adrenergic receptor down-regulation and that there is promise in gaining a better understanding of the biological mechanisms of differential response to β₂-agonists through GWAS.

Vyšlo v časopise: Genome-Wide Association Analysis in Asthma Subjects Identifies as a Novel Bronchodilator Response Gene. PLoS Genet 8(7): e32767. doi:10.1371/journal.pgen.1002824
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002824

Souhrn

Zdroje

1. American Lung Association 2006 Trends in Asthma Morbidity and Mortality New York, NY Epidemiology and Statistics Unit, Research and Program Services, American Lung Association

2. Global Initiative for Asthma Management and Prevention 1995 NHLBI/WHO Workshop Report National Institutes of Health, Bethesda US Department of Health and Human Services

3. NelsonHS 1995 Beta-adrenergic bronchodilators. N Engl J Med 333 499 506

4. LozaMJPennRB 2010 Regulation of T cells in airway disease by beta-agonist. Front Biosci (Schol Ed) 2 969 979

5. SalatheM 2002 Effects of beta-agonists on airway epithelial cells. J Allergy Clin Immunol 110 S275 281

6. ShoreSAMoorePE 2003 Regulation of beta-adrenergic responses in airway smooth muscle. Respir Physiol Neurobiol 137 179 195

7. JarttiT 2001 Asthma, asthma medication and autonomic nervous system dysfunction. Clin Physiol 21 260 269

8. DrazenJMSilvermanEKLeeTH 2000 Heterogeneity of therapeutic responses in asthma. Br Med Bull 56 1054 1070

9. MoffattMFGutIGDemenaisFStrachanDPBouzigonE 2010 A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363 1211 1221

10. TorgersonDGAmplefordEJChiuGYGaudermanWJGignouxCR 2011 Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 43 887 892

11. NiuTRogusJJChenCWangBYangJ 2000 Familial aggregation of bronchodilator response: a community-based study. Am J Respir Crit Care Med 162 1833 1837

12. HawkinsGAWeissSTBleeckerER 2008 Clinical consequences of ADRbeta2 polymorphisms. Pharmacogenomics 9 349 358

13. DrysdaleCMMcGrawDWStackCBStephensJCJudsonRS 2000 Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97 10483 10488

14. SilvermanEKKwiatkowskiDJSylviaJSLazarusRDrazenJM 2003 Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J Allergy Clin Immunol 112 870 876

15. TantisiraKGSmallKMLitonjuaAAWeissSTLiggettSB 2005 Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. Hum Mol Genet 14 1671 1677

16. PoonAHTantisiraKGLitonjuaAALazarusRXuJ 2008 Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. Pharmacogenet Genomics 18 373 382

17. LitonjuaAALasky-SuJSchneiterKTantisiraKGLazarusR 2008 ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 178 688 694

18. VonkJMPostmaDSMaarsinghHBruinenbergMKoppelmanGH 2010 Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response. Pharmacogenet Genomics 20 179 186

19. ManolioTA 2010 Genomewide association studies and assessment of the risk of disease. N Engl J Med 363 166 176

20. DalyAK 2010 Genome-wide association studies in pharmacogenomics. Nat Rev Genet 11 241 246

21. TantisiraKGLasky-SuJHaradaMMurphyALitonjuaAA 2011 Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 365 1173 1183

22. TakeuchiFMcGinnisRBourgeoisSBarnesCErikssonN 2009 A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet 5 e1000433 doi:10.1371/journal.pgen.1000433

23. BarberMJMangraviteLMHydeCLChasmanDISmithJD 2010 Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS ONE 5 e9763 doi:10.1371/journal.pone.0009763

24. SharmaSLitonjuaAATantisiraKGFuhlbriggeALSzeflerSJ 2008 Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 122 921 928 e924

25. American Thoracic Society 1991 Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144 1202 1218

26. WaalkensHJMerkusPJvan Essen-ZandvlietEEBrandPLGerritsenJ 1993 Assessment of bronchodilator response in children with asthma. Dutch CNSLD Study Group. Eur Respir J 6 645 651

27. Thierry-MiegDThierry-MiegJ 2006 AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1 S12 11 14

28. ZhuCHKimJShayJWWrightWE 2008 SGNP: an essential Stress Granule/Nucleolar Protein potentially involved in 5.8s rRNA processing/transport. PLoS ONE 3 e3716 doi:10.1371/journal.pone.0003716

29. IsraelEDrazenJMLiggettSBBousheyHACherniackRM 2000 The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 162 75 80

30. IsraelEChinchilliVMFordJGBousheyHACherniackR 2004 Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 1505 1512

31. TaylorDRDrazenJMHerbisonGPYandavaCNHancoxRJ 2000 Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 55 762 767

32. Contopoulos-IoannidisDGAlexiouGAGouviasTCIoannidisJP 2006 An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment. Pharmacogenet Genomics 16 705 711

33. Childhood Asthma Management Program Research Group 1999 The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 20 91 120

34. PetersSPAnthonisenNCastroMHolbrookJTIrvinCG 2007 Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 356 2027 2039

35. American Lung Association Asthma Clinical Research Centers 2007 Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 175 235 242

36. SilvermanESPalmerLJSubramaniamVHallockAMathewS 2004 Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 169 214 219

37. SilvermanESBaronRMPalmerLJLeLHallockA 2002 Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung. Am J Respir Cell Mol Biol 27 697 704

38. GuilbertTWMorganWJKrawiecMLemanskeRFJrSorknessC 2004 The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials 25 286 310

39. DenlingerLCSorknessCAChinchilliVMLemanskeRFJr 2007 Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol 119 3 11; quiz 12–13

40. PriceALPattersonNJPlengeRMWeinblattMEShadickNA 2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909

41. WillerCJSannaSJacksonAUScuteriABonnycastleLL 2008 Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 161 169

42. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575

43. LiptakT 1958 On the combination of independent tests. Magyar Tud Akad Mat Kutato Int Kozl 3 171 197

44. PruimRJWelchRPSannaSTeslovichTMChinesPS 2010 LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26 2336 2337

45. MooreWCBleeckerERCurran-EverettDErzurumSCAmeredesBT 2007 Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119 405 413

46. R Development Core Team 2008 R: A Language and Environment for Statistical Computing Vienna, Austria R Foundation for Statistical Computing

47. KoppelmanGHMeyersDAHowardTDZhengSLHawkinsGA 2009 Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med 180 929 935

48. MisiorAMDeshpandeDALozaMJPascualRMHippJD 2009 Glucocorticoid -⁠ and protein kinase A-dependent transcriptome regulation in airway smooth muscle. Am J Respir Cell Mol Biol 41 24 39

49. GautierLCopeLBolstadBMIrizarryRA 2004 affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20 307 315

50. SmythGK 2005 Limma: linear models for microarray data. GentlemanRCareyVDudoitSIrizarryRHuberW Bioinformatics and Computational Biology Solutions using R and Bioconductor New York Springer 397 420 editors. pp.

51. BenitaYCaoZGiallourakisCLiCGardetA 2010 Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood 115 5376 5384

52. PanettieriRAMurrayRKDePaloLRYadvishPAKotlikoffMI 1989 A human airway smooth muscle cell line that retains physiological responsiveness. Am J Physiol 256 C329 335

53. CooperPRMesarosACZhangJChristmasPStarkCM 2010 20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. PLoS ONE 5 e10235 doi:10.1371/journal.pone.0010235